Biomay AG

Vienna, Austria
No confirmed program data — ClinicalTrials.gov verification pending · Last scored 2026-09-07
76.3
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (11) ○ MHRA GMP

Quick Facts: Biomay AG

Signal Score
76.3/100 (as of 2026-09-07)
Quality Compliance
98.9/100
Headquarters
Vienna, Austria
Modalities
Plasmid
Active Programs
Data pending
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Biomay AG

Pure-play CDMO.

Signal Score & Pillar Breakdown

Scores are being republished. Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance 98.9
FDA InspectionsNo US records on file
EMA GMP Certificates11 on record
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesPlasmid
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity 53.0
Profile-based capacity assessment
Attribution not established (2)
These records are excluded from this company’s established evidence because their attribution is unresolved. This describes an evidence-linking limitation, not an assessment of the underlying regulatory findings.
Source Establishment named by the regulator Location Identifier
FDA inspection Biomat USA, Inc Zanesville, Ohio FDA/FEI=3024595229
FDA inspection Biomat USA Inc Killeen, Texas FDA/FEI=3022477122
Source records retained verbatim · attribution not established

Biomay AG EMA GMP Compliance 11 certificates

2026-02
2025-10
2024-03
2024-03
2024-03
2024-03
2024-03
2023-11
2023-10
2022-03
2022-03
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
481719-104874335 Biomay AG Austria 2026-02-19 COMPLIANT
484219-103674986 Biomay AG Austria 2025-10-16 COMPLIANT
481719-104568656 Biomay AG Austria 2024-03-13 COMPLIANT
481719-103425951 Biomay AG Austria 2024-03-13 COMPLIANT
481719-102752478 Biomay AG Austria 2024-03-13 COMPLIANT
481719-104874230 Biomay AG Austria 2024-03-13 COMPLIANT
481719-102570085 Biomay AG Austria 2024-03-13 COMPLIANT
484219-101573243 Biomay AG Austria 2023-11-23 COMPLIANT
481719-101983357 Biomay AG Austria 2023-10-11 COMPLIANT
484219-100395448 Biomay AG Austria 2022-03-17 COMPLIANT
484219-102096252 Biomay AG Austria 2022-03-17 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 06, 2026

Frequently Asked Questions About Biomay AG

Does Biomay AG hold EMA or MHRA GMP certificates?
CDMO Signal tracks 11 EMA GMP certificates for Biomay AG.
What is Biomay AG's CDMO Signal Score?
Biomay AG has a Signal Score of 76/100, based on quality, operations, financial stability, and capacity data.
Evaluating Biomay AG for a manufacturing program?
Use the free AI matchmaker to compare Biomay AG against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Plasmid CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Aldevron
Fargo, ND
Signal Score: 84.8
Plasmid, mRNA
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid